Live
ePaper
Search
Home > India > UPDATE 3-Capricor's Duchenne treatment fails to get FDA approval, shares sink

UPDATE 3-Capricor's Duchenne treatment fails to get FDA approval, shares sink

Written By:
Last Updated: November 21, 2026 06:51:36 IST

(Adds Capricor response in paragraphs 3 and 6) Nov 20 (Reuters) – The US Food and Drug Administration declined to approve Capricor Therapeutics' experimental cell therapy for a fatal inherited disease

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?